Erdosteine

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Erdosteine topic overview

The analysis highlights Applications, Pharmacodynamics and Safety profile as prominent areas in the source structure around Erdosteine.

Related topics: 37
Source areas: 7
Connected nodes: 44
Extracted relationships: 44
Concept neighborhoods: 12
Bridge connections: 44

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Pharmacodynamics · 21 topics

Safety profile · 7 topics

Contraindications · 3 topics

Overview · 3 topics

Clinical uses · 1 topics

Interaction with other medicinal products · 1 topics

Pharmacokinetics · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol): Interactive image
AHFS/Drugs.com: International Drug Names
ATC code: R05CB15 (WHO)
CAS Number: 84611-23-4 Y
ChEMBL: ChEMBL1697744
ChemSpider: 59073 Y

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Mucolytic Mucoactive agent
Thioether
First-pass metabolism First pass effect

Pharmacodynamics

Anti-oxidant Antioxidant
Oxidative stress
Inflammation
Antibiotics Antibiotic
Anti-inflammatory
Free radicals
Lipid peroxidation
Adhesin Bacterial adhesin
Respiratory infections Respiratory tract infection
Chronic Obstructive Pulmonary Disease
Exacerbations Exacerbation
Metanalysis Meta-analysis
Double-blind Blinded experiment
Placebo
Sub-analysis Post hoc analysis
Bronchiectasis
Rhinosinusitis Sinusitis
Nasal polyposis Nasal polyp
Ampicillin
Tracheobronchitis
Pneumonia

Pharmacokinetics

Pharmacokinetic Pharmacokinetics

Clinical uses

Global Initiative for Chronic Obstructive Lung Disease

Safety profile

Contraindications

Excipients Excipient
Hepatic cirrhosis Cirrhosis
Enzyme

Interaction with other medicinal products

Bronchodilators Bronchodilator

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Erdosteine connects Entity context

The extracted context around Erdosteine shows recurring relationship patterns in the source. For example, Erdosteine → Chronic Obstructive Pulmonary Disease, Clinical, COPD, It Another extracted example is Erdosteine → Countries, In, Otitis Media Secretorica, Several. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Clinical uses · 4

Erdosteine → Chronic Obstructive Pulmonary Disease, Clinical, COPD, It

related to Other activities · 4

Erdosteine → Countries, In, Otitis Media Secretorica, Several

related to Anti-oxidant and anti-inflammatory activity · 3

Erdosteine → COPD, Met, ROS

related to Antiadhesive activity · 3

Erdosteine → In, Met, The

related to Chronic Obstructive Pulmonary Disease · 3

Erdosteine → COPD, Evidence, These

related to Pharmacokinetics · 3

Erdosteine → Food, Met, The

related to Mucolytic activity · 2

Erdosteine → N-acetylcysteine, Several

related to Safety profile · 2

Erdosteine → Data, Frequency

3D model (JSmol) · 1

Erdosteine → Interactive image

AHFS/Drugs.com · 1

Erdosteine → International Drug Names

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

patients chronic copd exacerbations treatment mucolytic met respiratory molecule active oral activity drug mucus several mg clinical profile metabolism antibiotics

Erdosteine relationships Subject–Predicate–Object triples

TTTA extracted 44 structured relationships around Erdosteine. Examples in this analysis include Erdosteine → 3D model (JSmol) → Interactive image and Erdosteine → AHFS/Drugs.com → International Drug Names. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Erdosteine	3D model (JSmol)	Interactive image	1.00	infobox
Erdosteine	AHFS/Drugs.com	International Drug Names	1.00	infobox
Erdosteine	ATC code	R05CB15 (WHO)	1.00	infobox
Erdosteine	CAS Number	84611-23-4 Y	1.00	infobox
Erdosteine	ChEMBL	ChEMBL1697744	1.00	infobox
Erdosteine	ChemSpider	59073 Y	1.00	infobox
Erdosteine	CompTox Dashboard (EPA)	DTXSID8048735	1.00	infobox
Erdosteine	ECHA InfoCard	100.169.984	1.00	infobox
Erdosteine	Elimination half-life	1–3 hours	1.00	infobox
Erdosteine	Formula	C8H11NO4S2	1.00	infobox
Erdosteine	KEGG	D07383 Y	1.00	infobox
Erdosteine	Metabolism	liver	1.00	infobox
Erdosteine	Molar mass	249.30 g·mol−1	1.00	infobox
Erdosteine	Protein binding	65%	1.00	infobox
Erdosteine	PubChem CID	65632	1.00	infobox
Erdosteine	Routes of administration	By mouth, inhalation	1.00	infobox
Erdosteine	UNII	76J0853EKA	1.00	infobox
Erdosteine	is a	molecule with mucolytic activity	0.90	text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Erdosteine bring nearby vocabulary together. In this analysis, examples include Treatment, Copd and Patients. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Erdosteine
- Treatment
- Copd
- Patients
- Exacerbations
- Chronic
- Met
- Activity
- Demonstrated
- Efficacy
- Mucolytic
- Symptoms
- Mucus
erdosteine
- Treatment
- Copd
- Patients
- Exacerbations
- Chronic
- Met
- Activity
- Demonstrated
- Efficacy
- Mucolytic
- Symptoms
- Mucus
chronic obstructive pulmonary disease
- Pulmonary
- Disease
- Mucolytic
- Patients
- Mucus
- Respiratory
- Exacerbations
- Treatment
- Administration
- Disorders
- Copd
- Clinical
global initiative for chronic obstructive lung disease
- Pulmonary
- Disease
- Mucolytic
- Patients
- Mucus
- Respiratory
- Exacerbations
- Treatment
- Administration
- Disorders
- Copd
- Clinical
clinical uses
- Studies
- Mucus
- Respiratory
- Antibiotics
- Disease
- Disorders
- Drugs
- Metabolism
- Profile
- Pulmonary
- Reduction
- Safety
anti-oxidant
- Groups
- Able
- Administration
- Disease
- Disorders
- Drugs
- Metabolism
- Profile
- Pulmonary
- Safety
- Clinical
- Drug
first-pass metabolism
- Molecule
- Drug
- Anti-oxidant
- Administration
- Disease
- Disorders
- Drugs
- Profile
- Pulmonary
- Safety
- Clinical
- Mucolytic
mucolytic
- Disease
- Respiratory
- Exacerbations
- Copd
- Able
- Drugs
- Profile
- Pulmonary
- Risk
- Safety
- Clinical
- Mucus

Connections between topic areas Semantic bridges

For Erdosteine, one of the stronger structural bridges in this analysis connects Erdosteine with Pharmacodynamics. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Erdosteine — Pharmacodynamics · splits 23 ⟂ 22

Erdosteine — Safety profile · splits 37 ⟂ 8

Erdosteine — Overview · splits 41 ⟂ 4

Erdosteine — Contraindications · splits 41 ⟂ 4

Map overview Semantic statistics

Erdosteine

Nodes45

Edges44

Triples44

Avg. degree1.96

Density0.044444

Components1

Source & methodology

TTTA analyzes the structure around Erdosteine to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Pharmacodynamics & Safety profile, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Erdosteine · EN edition · Analysis: TopicsToTalkAbout